In this, the first of three videos in which Sunita Nasta, MD, FACP reviews findings from ASH on the aggressive lymphomas, Dr. Nasta considers mantle cell lymphomas. Her presentation includes an overview of the current induction and consolidation therapies for MCL at various stages of the disease and exposures to treatment, as well as a discussion of newer targeted agents and cellular therapies, including idelalisib, ibrutinib and temsirolimus.
To view other parts of this program:
Part 2: Diffuse Large Cell Lymphoma
Related Links
Published
December 6, 2016
Created by
BROADCASTMED